GL1X · GenesisL1 explorer

Research workbench

Crystal structure of PDE5A in complex with a novel inhibitor

Analyse Crystal structure of PDE5A in complex with a novel inhibitor in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6IWI
Type
protein
Length
290 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Cgmp-specific 3',5'-cyclic phosphodiesterase
EC
3.1.4.35
UniProt
O76074
Ligands
B0C, MG, ZN
Pockets
3 · best druggability 0.63

Structure

x-ray diffraction · 1 distinct chain · 71% helix, 0% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACgmp-specific 3',5'-cyclic phosphodiesterase (EC 3.1.4.35)protein29071% helix, 0% strandO76074

Ligands and binding sites

  • B0C · N-[3-(4,5-diethyl-6-oxo-1,6-dihydropyrimidin-2-yl)-4-propoxyphenyl]-2-(4-methylpiperazin-1-yl)acetamide · ligand · chains A
  • MG · Magnesium ion · metal · chains A
  • ZN · Zinc ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12560.630.8128MG, B0C
2610.550.8819empty
3560.400.8118empty

Compared structures

  • 6IWI · Crystal structure of PDE5A in complex with a novel inhibitor · the same entry in another collection · chain A against A, TM-score 1.00
  • O76074 · AlphaFold monomer V2.0 prediction for cgmp-specific 3',5'-cyclic phosphodiesterase… · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.